MoneyWorks4Me

Gland Pharma - Quaterly Results

20 May 2025 Evaluate
The sales slipped to Rs. 10303.53 millions for the March 2025 quarter as against Rs. 11748.30 millions during the year-ago period.Net profit declined -9.77% to Rs. 2899.99 millions from Rs. 3214.11 millions.Operating profit for the quarter ended March 2025 decreased to 4378.41 millions as compared to 4797.85 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 10303.53 11748.30 -12.30 41161.49 41674.28 -1.23 41161.49 41674.28 -1.23
Other Income 437.18 469.55 -6.89 2150.75 1666.66 29.05 2150.75 1666.66 29.05
PBIDT 4378.41 4797.85 -8.74 16576.93 15754.47 5.22 16576.93 15754.47 5.22
Interest 34.46 45.34 -24.00 228.37 78.43 191.18 228.37 78.43 191.18
PBDT 4343.95 4752.51 -8.60 16348.56 15676.04 4.29 16348.56 15676.04 4.29
Depreciation 430.72 425.63 1.20 1692.71 1621.07 4.42 1692.71 1621.07 4.42
PBT 3913.23 4326.88 -9.56 14655.85 14054.97 4.28 14655.85 14054.97 4.28
TAX 1013.24 1112.77 -8.94 3758.32 3621.72 3.77 3758.32 3621.72 3.77
Deferred Tax 22.52 105.98 -78.75 91.24 246.84 -63.04 91.24 246.84 -63.04
PAT 2899.99 3214.11 -9.77 10897.53 10433.25 4.45 10897.53 10433.25 4.45
Equity 164.76 164.71 0.03 164.76 164.71 0.03 164.76 164.71 0.03
PBIDTM(%) 42.49 40.84 4.05 40.27 37.80 6.53 40.27 37.80 6.53
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..